Company: SRPT
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0000950170-25-083131
Chunk: 3

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-06-06
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                                                              
   Number                                                                                                                                               
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     10.1      Amendment No. 4 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan                                                             
     10.2      Amendment No. 3 to the Sarepta Therapeutics, Inc. Amended and Restated 2013 Employee Stock Purchase Plan                                 
      104      The cover page from this Current Report on Form 8-K of Sarepta Therapeutics, Inc., formatted in Inline XBRL and included as Exhibit 101  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                        Sarepta Therapeutics, Inc.             
  Date:      June 6, 2025      By:      /s/ Douglas S. Ingram                  
                                        Douglas S. Ingram